Tag: Data Analytics

2024 Outlook: Data-Driven Transformations in the Indian Insurance Brokerage Industry

2024 Outlook: Data-Driven Transformations in the Indian Insurance Brokerage Industry

The Indian insurance brokerage ecosystem has witnessed rapid change in recent years, driven by data-driven transformations. This has revamped overall decision-making, marketing, and customer support in a major way and the trend looks set to continue in the future. Here is a closer look at how data-based transformation will ultimately impact the operations of brokerages in the Indian insurance market in 2024 and beyond.  Ways in Which Insurance Brokers Will Leverage Data Data analytics in insurance will be a major game-changer shortly for brokers. Indian insurance brokerages will ultimately turn to these models of operation.  Brokerages will also embrace technology to offer customers better services across WhatsApp, emails, SMS, or phone among other channels. They can reach out better to customers at the right time and place along with forecasting buying trends and patterns. Data analytics will help with customer behavior analysis which will unearth several invaluable insights in turn for brokers. The end goal will be to provide customised and need-based solutions across segments. Target consumers can be easily identified and segmented while products can be tailored to meet their needs. Brokerages can also leverage technology to help insurers with better underwriting, eliminating fraud enabling risk management, and maximising usage of alternate data sources. They can also use data for collaborations with other parties for specific use cases and scenarios.  These are some of how Indian insurance brokerages will gradually adopt data-driven transformations to help build competitive advantages throughout the insurance landscape.  FAQs What key data-driven transformations are anticipated for the Indian insurance brokerage industry in 2024?  The Indian insurance brokerage industry in 2024 could adopt several data-driven transformations including personalised customer products and services along with automated and faster claim settlements and processing. They can also delve into personalised pricing decisions and models to benefit their customers.  What role will emerging technologies play in shaping the data-driven landscape of Indian insurance brokerages in 2024?  Several emerging technologies like AI, automation, machine learning, and data analytics will have a vital role to play in shaping the entire data-based Indian insurance brokerage landscape in 2024. They will make it easier to build customer profiles, target and segment customers in specific categories, predict customer buying patterns based on behavioural habits and preferences, and customise products/services and pricing accordingly among many other use cases.  In what ways will data analytics impact risk management and decision-making processes for Indian insurance brokers in 2024? Data analytics will help Indian insurance brokers make better decisions and manage risks more effectively in 2024 and beyond. Analytics will help them identify potential risks at the customer’s end and also eliminate the chances of fraud. At the same time, it will help make better decisions on personalising pricing as per customer habits and lifestyle preferences. It will also help make better decisions on policy issuance depending on customer data from multiple channels. 

Read More »
How Indian BFSI Firms are Thriving through Data-Driven Strategies

How Indian BFSI Firms are Thriving through Data-Driven Strategies

BFSI firms in India are innovatively leveraging data-driven strategies to thrive and flourish in recent times. Online banking has already generated customer expectations regarding cutting-edge services irrespective of location and time. Open banking and embedded finance have also raised the bar further, enabling customers to get credits through non-bank enterprises. Open banking is also enabling third-party access through APIs to financial information. With the increase in advanced banking operations, customers are steadily expecting their institutions to anticipate their needs better.  At the same time, another indicator for BFSI firms about using data analytics in BFSI is to enable better customer experiences for future growth. A Salesforce report in 2019 covered 8,000 business customers and buyers globally and reported how 84% of customers feel that customer experiences are as crucial as the services and products offered by any financial institution. Data shared across multiple touch points and channels have thus opened up several new opportunities for BFSI players throughout the Indian finance sector to flourish amidst a competitive landscape.  How Data-Driven Strategies are Helping BFSI Firms Flourish  Data analytics in BFSI and other data-driven strategies are enabling BFSI firms in India to thrive and grow in the present scenario. Here are some pointers worth noting in this regard.  It is a fast-changing world that necessitates the usage of data-driven strategies across the board for BFSI firms. The digital banking platform segment is already expected to grow by a whopping 11.2% (CAGR or compounded annual growth rate) from 2021 to the year 2026. Bots are leveraging data to provide better customer service across touchpoints without requiring branch visits or conversations with agents. They can service customer requests easily while handling other activities seamlessly.  Conversational AI platforms are also using NLP that is integrated with IVR systems. These systems can take calls by answering repetitive questions and prevent any customer panic. Customers are assisted in swiftly resolving queries while calls that are complex are transferred to agents. Banks are offering branch-like services with data-driven strategies, building customer profiles/personas, predicting behaviour, and recommending ideal financial services and products.   Fraud detection and security models are trained on continual incoming data, helping BFSI firms know more about normalised activity levels, transaction anomalies, deviations, and more. Another method is behavior profiling which studies customer data and accounts to build profiles and understand where/what kind of transactions have taken place. Prescriptive analytics also helps leverage the data that is gathered by predictive analytics to recommend the measures to be taken once fraud is identified. These are some of the many ways in which data-driven approaches are helping BFSI players thrive in an increasingly competitive Indian finance sector. As they say worldwide, data is the new oil and it will soon be the differentiator and competitive advantage that companies in every sector will want to harness, banking and financial services included.  FAQs What key benefits do Indian BFSI firms experience through the adoption of data-driven approaches?  Data-driven approaches are helping BFSI firms in India obtain several major benefits including the ability to personalise products/services for customers, identify and eliminate fraud, predict risks and manage them accordingly, and a lot more.  In what ways are data-driven strategies enhancing decision-making within the Indian BFSI sector? Data-driven strategies are boosting overall decision-making within the Indian BFSI sector. Banks and financial institutions are leveraging data to make better decisions on granting loans or other products, offering personalised services or solutions to customers, identifying and mitigating risks, and so on. 

Read More »
Data-Driven Decision Making: How Advanced Analytics Is Shaping Fintech Strategies

Data-Driven Decision Making: How Advanced Analytics Is Shaping Fintech Strategies

Data-driven decision-making and better fintech strategies are a result of advanced analytics in fintech, a trend which is making the whole sector sit up and take notice of their immense potential. Open banking and big data analytics are shaping the financial sector as it prepares for a more customer-centric and digital shift in the near future.  How has Data Analytics in Finance Been a Game-Changer for the Industry? Advanced analytics in fintech has completely changed the operational rules of the game for these platforms along with other financial institutions at large. Customers now have more control over their finances with open banking and expect more personalised experiences as a result. Big data analytics in finance is forecasted to continue its growth momentum, leading to newer fintech innovation opportunities. More platforms and market players will look at leveraging big data to deliver better services to customers along with tailored and personalised products and experiences.  Here’s how advanced analytics in fintech can help industry stakeholders in the current scenario:  As can be seen, advanced analytics in fintech has several potential benefits that will usher in a whole new era of smart banking and finance solutions in the future. Companies can easily optimise customer acquisition with data-driven marketing and personalisation. They can also scale up customer retention as a result, while identifying better opportunities for up-selling or cross-selling along with communicating better with customers in a personalised manner. They can also combat cyber-security issues and fraud better through machine learning algorithms that identify unusual patterns, anomalies, and other suspicious activities. AI and automation can be used to swiftly gather insights from vast amounts of information while also enabling automated customer service and communication via Chatbots.  Sounds interesting? Analytics and AI are poised to bring in a whole new world for customers and fintech players alike. The best part is that there are only upsides for all stakeholders in the process.  FAQs How is advanced analytics revolutionising data-driven decision-making in the fintech industry? Advanced analytics is helping fintech players make data-driven decisions related to personalised customer communication, marketing, offering tailored products and services, meeting customer demand, and also in terms of evaluating market conditions and responding to them more accurately.  What types of data sources and analytics tools are fintech companies leveraging to gain a competitive edge? Fintech companies are leveraging various data sources including their own databases, online channels and social media platforms, POS transactions and other transaction histories, and more. They are also leveraging AI and machine learning along with automation and big data analytics to gain a competitive edge in their respective market segments.  How can data-driven insights lead to more personalised fintech products and services for customers? Data–driven insights help fintech companies build personalised customer profiles and offer customised products and services to customers based on their transaction history, behavioural habits, preferences, and other parameters.  What are the key challenges and considerations when implementing advanced analytics in fintech strategy development? Some of the major considerations or challenges while implementing advanced analytics in fintech strategy development include regulatory norms, customer consent and data privacy, and the safety of customer data.

Read More »
Top Data Analytics Trends in Pharma to Look Out For in 2024

Top Data Analytics Trends in Pharma to Look Out For in 2024

There are numerous data analytics trends in pharma that have disrupted the sector steadily in recent years. The industry itself is seeing a major integration of things like blockchain, Industry 4.0 techniques, and AI (artificial intelligence) among other game-changers.  Along with pharma data analysis and the usage of real-world data for collecting patient experiences, blockchain for secure transactions, and even managing patient records, there are several use cases worth considering in this regard. There is also a steady emphasis on offering augmented, virtual, and mixed-reality solutions throughout the industry spectrum. Here are a few pharmaceutical industry trends worth noting from a data analytics standpoint.  Pharma Analytics 2024 Trends  Here are some of the top data analytics trends in pharma that are worth noting.  These are some of the top data analytics trends in pharma that deserve to be noted in the current scenario. Data analysis and insights are completely changing the game for pharmaceutical companies in terms of enabling benefits throughout the entire spectrum.  FAQs How is the utilization of big data and advanced analytics improving drug discovery and development processes? Big data analytics works to reduce the costs and time of clinical trials. Through the usage of machine learning (ML) algorithms, pharmaceutical companies can easily identify sub-groups of patients which are more likely to respond to specific treatments. Researchers can also design more targeted and smaller trials that will succeed more. Data sets can be integrated with big data from diverse sources. Through this analysis, researchers can easily identify drug indicators, newer targets, and drug response biomarkers with lower risks.  What role does artificial intelligence play in optimizing pharmaceutical research and manufacturing operations? AI-based algorithms may optimize and analyze drug candidates by taking several aspects into account. These include pharmacokinetics, safety, and efficacy levels. It enables researchers to fine-tune specific therapeutic molecules to boost overall effectiveness while lowering side effects simultaneously. Predictive maintenance is also used through artificial intelligence (AI) throughout the manufacturing process. It may be applied to production data for enhancing maintenance planning and the prediction of failures.  What challenges and opportunities are associated with data analytics in pharmaceuticals, and how can companies stay competitive in this evolving landscape? Data engineering and analysis come with various challenges including the management of data from diverse sources while also sticking to stringent regulatory requirements and safeguarding the privacy levels of patients. There are varied challenges relating to data quality along with data silos, governance, and integration. These can be overcome through master data management platforms which ensure more reliable and accurate data that helps companies build their competitive advantages accordingly. 

Read More »
Analytics-Driven Personalisation: Redefining the Customer Experience in Banking

Analytics-Driven Personalisation: Redefining the Customer Experience in Banking

Analytics-driven personalisation is the biggest recent trend that has completely changed the game in terms of enabling personalised banking along with improved customer experience in banking. Digital transactions, payments, and banking platforms have completely changed the modus operandi as far as both customers and executives are concerned. At the same time, the higher digital engagement and transaction volumes lead to the generation of huge amounts of data on a daily basis. This is in the form of both non-transactional and transactional information.  Banks are now finding several merits in tapping and analysing this data to gain invaluable insights for positively transforming customer experiences and processes. Technologies like banking analytics are being used in tandem with machine learning, artificial intelligence, and big data analytics to generate the best possible results for banks in this context. Even McKinsey Global has stated how data-driven entities are 23 times likelier to acquire new customers, while being six times likelier to retain them and 19 times as likely to be profitable due to this aspect.  Another key aspect lies in the fact that banking analytics or data analytics in this segment had a value of approximately $4.93 billion in 2021 and is estimated to hit $28.11 billion within 2031 (indicating compounded annual growth rates or CAGR of 19.4%). There are several data or touch points for customers including websites, mobile apps, digital transactions, social media platforms and a lot more. Rich data can be used for redefining customer experiences while also predicting customer engagement and mapping the journey.  How Analytics-Driven Personalisation is the Key Factor When it comes to offering personalised banking and redefining customer experiences, big-data analytics is the key element that institutions are looking to leverage in the current scenario. Here are some pointers worth noting in this regard.  Several banks and financial institutions have multiple products for customers which cater to varying requirements. Redefining customer experiences thus becomes a major differentiator for these financial institutions in order to enhance customer satisfaction and retention levels alike. Gaining a better understanding of customers and identifying gaps or potential issues will also help improve the overall experience for customers while enabling more personalisation at the same time with full scalability.  What are the challenges of data analytics in banking?  There are a few challenges of leveraging banking analytics that institutions also need to be aware of. These include:  However, analytics-driven personalisation is the biggest trend that will completely reshape customer experiences across banks and financial institutions. Customers now engage across several touchpoints and expect more personalised banking solutions and quick assistance and support for their queries. Hence, institutions will have to rely more on data analysis and insights to make better decisions that lead to improved customer experiences and higher retention. However, maintaining a customer-centric approach is the biggest takeaway that banks should keep at the forefront while scaling up data analytics initiatives simultaneously.  FAQs Analytics-driven personalisation greatly enhances the banking experience for any customer. Banks get a full view of the customer profile and specific needs, pain points and requirements. Hence, they can customise their offerings and solutions to meet these needs while solving the pain points and making sure that the customer gets the right solutions at the right time.  Both transactional and non-transactional data are used for driving analytics-driven personalisation in banking. This includes data directly gathered from transactions across multiple channels and also other data from surveys, forms, websites, mobile applications, social media platforms and many other sources.  There are a few considerations and challenges that banks should keep in mind while implementing personalisation through analytics. Data quality and integrity should be a major focus area, since poor quality may completely jeopardise the whole process. Other considerations include data silos, gathering disparate data across systems, integration and dealing with legacy infrastructure.  With more personalised services and engagement, customer experiences naturally improve over time. This leads to higher loyalty and superior engagement since customers get solutions tailored to their needs and their pain points are addressed by banks swiftly due to analytics-driven insights.

Read More »
Latest Technologies and Future Trends by Top Key Players Forecast to 2030

Latest Technologies and Future Trends by Top Key Players Forecast to 2030

Several emerging technologies are poised to bring about a massive industry transformation as per reports. What is the forecast for future trends and the top key players till 2030? Here’s finding out.  Major Findings Here are some interesting findings related to technological advancements and technological disruptions throughout industries. It also offers insights into the future trends regarding emerging technologies.  Some Other Crucial Insights Here are a few other innovation forecast moot points for the period till 2030:  As can be seen, widespread transformation is at the core of business operations and efficiencies in the period till 2030. What the world is currently witnessing is a transitional phase with several emerging technologies being adopted by leading players in the Asia-Pacific and even worldwide. What is evident is that 2030 will push the bar well higher in terms of disruptions and eventual progress.  FAQs Some of the technologies that are already shaping the business landscape include automation and artificial intelligence, along with machine learning and IoT (Internet of Things). Other examples include data analytics and cloud computing along with blockchain technology. Organizations are steadily embracing these technologies to boost efficiency and offer more personalization to customers while also streamlining their internal operations or business processes. By 2030, the physical and digital worlds will also merge with technologies like AR, VR and 3D being used for creating digital twins in sectors like healthcare, manufacturing, real estate and more. There will also be a shift towards data native from cloud-native along with generative AI usage for closing up gaps between insights and data.  2. Who are the key players in these emerging technologies, and what are their roles in driving innovation? There are several key players for these emerging technologies from multiple standpoints. Countries like Japan, India, South Korea, and China are at the cusp of greater breakthroughs in terms of technological integration into the public and corporate spheres for greater efficiency, mitigation of risks, and many other purposes. At the same time, leading tech giants have a big role to play in terms of innovation and experimentation in order to drive future progress. The biggest players in these segments are chief technology officers or CTOs of companies. They have a vital role in terms of encouraging more innovation and building future technology blueprints for organizations.  There are a few challenges linked to the adoption of new technologies. These include legacy systems and perspectives, lack of training or skill sets, costs of new technologies and tools, and the speed of technological advancements, along with privacy concerns. The latter can be addressed through encryption measures, audits, and compliance with better regulations. Steady investments in up-skilling, training, and future-ready digital infrastructure are also the way forward with regard to tackling these challenges.  Several emerging technologies are poised to have a disruptive effect on various global sectors. Retail will witness a complete revamping of business strategies and models, becoming more personalized and data-driven with technological disruption. Industries like healthcare, manufacturing, insurance and finance should also witness major disruptions in the near future. 

Read More »
Addressing drug shortages with advanced analytics

Addressing drug shortages with advanced analytics

Drug shortages have become a part and parcel of modern healthcare systems due to several reasons. While there is a sizeable economic impact of drug shortages for manufacturers and pharmacies alike, there are widespread community and social disadvantages as well. Pharmacies or clinics running out of medicine stocks are representatives of a scenario that is often witnessed worldwide and with frightening consequences.  For example, Europe is already seeing shortages of commonly-used medicines. A survey by the Pharmaceutical Group of the European Union (EU) had 100% of 29 member nations reporting shortages of medicines amongst community pharmacists. 76% also stated how shortages had worsened than the earlier year (the survey was implemented between 14th November and 31st December 2022). The UK is also witnessing HRT shortages according to reports, while hospitals in the U.S. are also reporting issues with procurement for liquid ibuprofen, while ADHD diagnoses have gone up in the U.S. as well, leading to shortages of vital drugs for the same. Mexico is witnessing chronic shortages and unfulfilled prescriptions and supply fluctuations and disruptions have been seen widely throughout Asia too.  What are the reasons for medicine shortages?  Wondering about the reason for drug shortages? There are quite a few that can be noted in this context:  Higher seasonal illness outbreaks in the aftermath of COVID-19, leading to skyrocketing average annual demand for medicines that is higher than normal in several categories.  The inability of pharmaceutical companies to meet such unprecedented demand, with excess capacity restricted for cost control.  Global supply chain impact along with higher energy costs and inflation have impacted global drug manufacturers who have to contend with pricing measures.  Stockpiling by customers due to sudden drug shortages.  Over-prescribing by the system.  Reports estimate that the National Health Service in the UK loses a whopping 300 million pounds annually owing to partially-used or unused medication which cannot be reused or recycled.  Lack of systems for forecasting and identifying supply shortages, while ensuring proper inventory management.  Drug Shortage Solutions That May Work  There are a few drug shortage solutions that may be effective for combating and reducing shortages.  Data and analytics are enabling better access towards medicines worldwide while enabling superior supply and demand management for individual patients and pharmacies alike.  Real-time pharmacy, hospital, and clinical data will enable a proper understanding of the demand for specific drugs/medical products.  Leveraging electronic and public health records for enabling healthcare stakeholders to report demand figures for drugs, without revealing confidential patient data.  Opportunities for better inventory and supply chain management with AI (artificial intelligence) and machine learning (ML).  Generic entities may leverage smarter technologies for lowering manufacturing costs by up to 20% while enhancing production. Smarter and connected factories with proper insights and data analysis can enable higher savings and reliable deliveries.  Companies may look at higher procurement of local active ingredients while depending on go-to nations for the same. Boosting supply and production levels, along with harnessing real-time data analytics will enable tackling this scenario.  Supervised machine learning and analytics models can help in forecasting/predicting shortages for most drugs used throughout various categories, price points, and age groups.  Modelling can enable healthcare stakeholders to understand more about the issues behind drug shortages while analytics can also help predict demand for specific drugs based on historical data and current trends.  Pharmacies and other players may not have access to data on the supply side, although they have demand-side information. They will be able to gain more visibility into the supply chains of manufacturers with an integrated information-sharing system.  Data analytics-driven insights for optimizing orders and eventually lowering the effect of drug shortages on pharmaceutical and healthcare operations.  Systems for tracking and reporting drug shortages, including aspects like the frequency, drugs involved, period, causes, duration, managing strategies, impacts, and future shortages too.  Real-time identification and tracking of patients receiving shorter supplies of drugs by hospitals, clinics, and pharmacies. Immediate patient identification regulations for capturing present drug utilization across multiple categories.  Real-time identification and addressing situations along with finding out drugs in shorter supply. Predictive abilities enable higher time for researching material for alternative agents or making suitable arrangements for drug acquisition from other sites or facilities.  Once supply levels normalize for a drug, pharmacists and healthcare stakeholders may discontinue their surveillance regulations without waiting for technical assistance. Real-time data-filtering and reporting abilities are leveraged for viewing drug usage trends and prescription patterns throughout healthcare systems. These insights may enable higher standardization of drug management across institutions, while also facilitating better training of clinicians for lowering care variations.  Advanced data analytics will help address drug shortages and enable better inventory management simultaneously. However, suitable implementation, technological integration, and awareness are necessary for the same.  FAQs How can advanced analytics be used to address drug shortages? Advanced analytics can be deployed for tackling drug shortages through real-time tracking and surveillance of prescription trends and drug demand, forecasting shortages, and enabling better drug supply management.  What are the benefits of using advanced analytics to address drug shortages? Advanced analytics goes a long way towards helping tackle drug shortages, enabling forecasting future demand and shortages, identifying patterns for better management, and also enabling better global medicine access.  What are the challenges of using advanced analytics to address drug shortages? Challenges include technological integration, legacy systems integration, awareness regarding best practices, quality data generation, and more.  What are the best practices for implementing advanced analytics for drug shortage management? Best practices include unified and integrated public databases, suitable data modelling systems, suitable protocols for data security and privacy, and swift reporting mechanisms for demand and shortages.

Read More »
Data analytics plays a crucial role in clinical trial design and analysis by providing valuable insights into the effectiveness of new treatments and therapies.

The role of data analytics in clinical trial design and analysis

What is the role of data analysis in clinical trials? Can there be better clinical trial data analysis using R and other technologies? Is there a case for using big data analysis in clinical trials? Experts would certainly say Yes to all these questions. Clinical trials themselves have gone through sweeping changes over the last decade, with several new developments in immunotherapy, stem cell research, genomics, and cancer therapy among numerous segments. At the same time, there has been a transformation in the implementation of clinical trials and the process of identifying and developing necessary drugs.  To cite a few examples of the growing need for clinical trial data analysis, researchers gain quicker insights through the evaluation of databases of real-world patient information and the generation of synthetic control arms, while identifying drug targets alongside. They can also evaluate drug performance post-regulatory approvals in this case. This has lowered the cost and time linked to trials while lowering the overall burden on patients and enabling faster go-to-market timelines for drugs too.  What is driving data analysis in clinical trials?  Clinical trial data analysis is being majorly driven by AI (artificial intelligence) along with ML (machine learning), enabling the capabilities of collection, analysis, and production of insights from massive amounts of real-time data at scale, which is way faster than manual methods. The analysis and processing of medical imaging data for clinical trials, along with tapping data from other sources is enabling innovation of the entire process while being suitable for supporting the discovery procedure in terms of quickening the trials, go-to-market approaches, and launches.  The data volumes have greatly increased over the last few years, with more wearable usage, genomic and genetic understanding of individuals, proteomic and metabolomic profiles, and detailed clinical histories of patients derived from electronic health records. Reports indicate 30% of the data volumes of the world are generated by the global healthcare industry. The CAGR (compound annual growth rate) for healthcare data will touch 36% by the year 2025 as well. The volume of patient data in clinical systems has already grown by a whopping 500% to 2020 from 2016.  Data analysis in clinical trials- What else should you note?  Here are a few factors that are worth noting:  Synthetic control arm development  The role of data analysis in clinical trials is even more evident when one considers the development of synthetic control arms. Clinical drug discovery and trials may be fast-tracked while enhancing success rates and designs of clinical trials. Synthetic control arms may help in overcoming challenges linked to patient stratification and also lower the time required for medical treatment development. It may also enable better recruitment of patients through resolving concerns about getting placebos and enabling better management of diverse and large-sized trials.  Synthetic control arms tap into both historical clinical trials and real-world data for modelling patient control groups and doing away with the requirement for the administration of placebo treatments for patients which may hinder their health. It may negatively impact patient outcomes and enrolment in trials. The approach may work better for rare ailments where populations of patients are tinier and the lifespan is also shorter owing to the disease’s virulent nature. Using such technologies for clinical trials and bringing them closer to end-patients may significantly lower the overall inconveniences of travelling to research spots/sites and also the issue related to consistent tests.  ML and AI for better discovery of drugs ML and AI may enable a quicker analysis of data sets gathered earlier and at a swifter rate for clinicians, ensuring higher reliability and efficiency in turn. The integration of synthetic control arms in mainstream research will offer new possibilities in terms of transforming the development of drugs.  With an increase in the count of data sources including health apps, personal wearables and other devices, electronic medical records, and other patient data, these may well become the safest and quickest mechanisms for tapping real-world data for better research into ailments with sizeable patient populations. Researchers may achieve greater patient populations which are homogenous and get vital insights alongside. Here are some other points worth noting:  The outcomes of clinical trials are major metrics with regard to performance, at least as far as companies and investors are concerned. They are also the beginning of collaborations between patients, groups, and the healthcare sector at large. Hence, there is a clearly defined need for big data analysis in clinical trials as evident through the above-mentioned aspects.  FAQs How can data analytics be used in clinical trial design and analysis? Data analytics can be readily used for clinical trial design and analysis, expanding patient selection criteria, swiftly sifting through various parameters and helping researchers better target matching patients who match the criteria for exclusion and inclusion. Data analysis methods also enable better conclusions from data while also improving clinical trial design due to better visibility of the possible/predicted risk-reward outcomes.  What are the benefits of using data analytics in clinical trial design and analysis? The advantages of using data analytics in clinical trial design and analysis include the integration of data across diverse sources, inclusive of third parties. Researchers get more flexibility in terms of research, finding it easier to analyze clinical information. Predictive analytics and other tools are enabling swifter disease detection and superior monitoring.  What are the challenges of using data analytics in clinical trial design and analysis? There are several challenges in using data analytics for the analysis and design of clinical trials. These include the unavailability of skilled and experienced resources to implement big data analytics technologies, data integration issues, the uncertainty of the management process, storage and quick retrieval aspects, confidentiality and privacy aspects and the absence of suitable data governance processes.  What are the best practices for implementing data analytics in clinical trial design and analysis? There are numerous best practices for the implementation of data analytics for the analysis and design of clinical trials. These include good clinical data management practices, clinical practices, data governance

Read More »
Digital Behavior Analytics in Insurance

Why Digital Behaviour Analytics Should Be A Top Priority For The Insurers

Behaviour analytics in insurance is steadily gaining ground, with the steady evolution of consumer demands and an increasing focus on more flexibility and personalisation of offerings. User behaviour analytics is crucial for helping insurance companies meet varying and evolving requirements better while gaining invaluable insights in the process. Predominant user behaviour analytics software tools enable data analytics in a more specific form for the prediction and understanding of the habits of consumers.  How Behaviour Analytics In Insurance Are Beneficial And Other Vital Aspects   Predictive analytics of consumer behaviour enables diverse use cases for insurers, ranging from customised services to taking measures to combat fraud. Insurers usually use predictive analytics customer behaviour for gaining newer insights into consumer habits and offering more personalised services including things like recommendations, cross-selling new offerings, and lower premiums for safer drivers or healthy customers, or even healthy living tips for reducing claims in the future.  These are only a few examples of the usage of behaviour analytics in insurance.  Not for nothing has the user behaviour analytics market witnessed growth by leaps and bounds. This technology can be spread throughout the entire value chain by insurance companies and it is fast becoming a priority.  Along with smoother implementation and the right software tools, the importance of proper behavioural analytics security is also a focus point for insurance companies.  This is important since there is a huge volume of confidential data that is being gathered and analysed across segments. Hence, ensuring proper security is necessary at multiple levels.  Customers are now looking for more customised experiences with their insurers. 1/5th of insurance buyers reportedly state how their insurers do not provide any personalisation although 80% of them want the same.  This has been outlined in a DataArt report that takes information from Youbiquity Finance. At the same time, 77% of people surveyed in the report stated that they were eager to exchange behavioural information for getting customised services.  Some More Reasons And Use Cases For Behavioural Analytics In Insurance  The biggest reason for leveraging behavioural analytics in insurance is that customers are now looking for more flexibility, control, transparency, and customisation according to industry experts.  They want a scenario where their insurance costs are reflective of their specific behaviours and wish to tailor their insurance plans to their lifestyles.  For instance, if a consumer is medically in prime condition, then he/she will want this aspect to be reflected in premiums for policies.  Automotive insurance has been a great hunting ground for testing behavioural analytics for many insurance companies. Telematics devices in vehicles have helped generate data which is enabling price reductions and other benefits.  Life insurance is another category where customers are looking at evolving coverage amounts and controllable tenures.  Behavioural analytics is already helping people re-evaluate their requirements on a regular basis. Insurance companies will be able to tap these analytics to identify higher-risk consumers while meeting market requirements.  Global trends indicate how 5% of patients account for almost half of spending on healthcare. Hence, predictive analytics will play a crucial role in helping insurance companies identify risk factors for patients before these cases turn problematic.  These analytics can also enable firms to evaluate the regular activities of policyholders and responses in order to judge the various risks faced by them.  This will help in the removal of activities that might otherwise lead to premium increases for policies. Insurance companies can also move towards a more advisory role that is tailored toward the interests of the consumer. These analytics may also help prevent the occurrence of claims in many cases.  Behavioural analytics has been successful with regard to reducing losses, understanding customer interactions and networks within the ecosystem, and propensity modeling. It has also helped cross-sell various offerings along with up-selling whenever the time is ripe. It has also enabled insurance companies to swiftly offer assistance to customers at the time of claims and in other scenarios as well.  Hence, these benefits make a compelling case for the usage of user behaviour analytics by insurance firms.  FAQs What is digital behaviour analytics? Digital behaviour analytics is a specific form of data analytics that measures the user habits of consumers. It tracks consumer activity and interactions, along with their behavioural patterns in order to identify their needs, risks, and offer them more personalised solutions.  Why is digital behaviour analytics important for insurers? Insurers benefit from using digital behaviour analytics, since they can identify high-risk customers and instances while combating fraud and lowering claims and losses. They can also personalise their products and recommendations for consumers, giving them tailored solutions for various needs. At the same time, insurers can use these analytics to cross-sell/up-sell along with adopting an advisory role for customers.  What types of data can be analysed using digital behaviour analytics? Various types of data can be analysed through digital behaviour analytics. This includes customer interactions and activities throughout social media platforms and on the internet, along with their activity across various sites and applications. In-store, web-browsing, survey, advertising, and customer service data can also be analysed, to name a few sources. 

Read More »
MENU
CONTACT US

Let’s connect!

Loading form…

Almost there!

Download the report

    Privacy Policy.